Skip to main content
. Author manuscript; available in PMC: 2010 Sep 15.
Published in final edited form as: Clin Cancer Res. 2009 Sep 1;15(18):5937–5944. doi: 10.1158/1078-0432.CCR-08-3282

Table 1.

Study Cohorts

Cohort BA7072
Concentration
In Vitro
(µg/mL)
Nucleated
Cells
Infused
Product
Configuration
Disease Type
(No. Patients)
Total
No.
Patients
Breast Ovarian Colorectal
1 10 1 × 109 Fresh and
Cryopreserveda
1 3 1 5
2 40 1 × 109 Fresh and
Cryopreserveda
2 1 2 5
3 40 1 × 109 Cryopreserved
Onlyb
8 0 0 8
a

One infusion of fresh lapuleucel-T followed by 2 infusions of cryopreserved lapuleucel-T.

b

Three infusions of cryopreserved lapuleucel-T.